HGH Fragment 176-191 2mg – 10 vials

HGH Fragment 176-191 is a synthetic peptide analogue corresponding to amino acids 176 to 191 of the human growth hormone (HGH) sequence. Unlike full-length HGH, this truncated fragment retains the lipolytic properties of the parent molecule without the associated mitogenic or insulin-desensitising effects, making it a highly selective tool in metabolic research.

The peptide is believed to regulate fat metabolism by mimicking the way natural growth hormone controls lipolysis and inhibits lipogenesis. It achieves this without binding to the GH receptor in the conventional manner, suggesting an independent mechanism of action that has attracted significant interest in adipose tissue and obesity research.

Researchers have employed HGH Fragment 176-191 in studies examining fat cell mobilisation, energy expenditure, and the biochemical pathways underpinning metabolic dysfunction. Its selectivity and stability make it a valuable compound for in vitro and in vivo experimental models.

Each vial contains 2mg of HGH Fragment 176-191 as a lyophilised powder with a purity exceeding 98%, verified by HPLC analysis. The molecular formula is C₇₈H₁₂₃N₂₃O₂₃S₂, with a molecular weight of 1817.12 g/mol and CAS number 221231-10-3. Store at -20°C, protected from light and moisture. Reconstitute with bacteriostatic water prior to use.

For research purposes only. Not for human use.